| VSMAX | WEMMX | VSMAX / WEMMX | |
| Total Expense Ratio | 0.05 | 1.53 | 3% |
| Annual Report Gross Expense Ratio | 0.05 | 1.53 | 3% |
| Fund Existence | 26 years | 28 years | - |
| Gain YTD | 14.588 | 25.385 | 57% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 3000 | 1000 | 300% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 189B | 203M | 93,103% |
| Annual Yield % from dividends | 1.21 | 0.35 | 342% |
| Returns for 1 year | 22.58 | 9.27 | 244% |
| Returns for 3 years | 43.42 | -20.40 | -213% |
| Returns for 5 years | 35.11 | -41.63 | -84% |
| Returns for 10 years | 155.96 | -24.55 | -635% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BQLCX | 23.42 | 0.17 | +0.73% |
| Bright Rock Quality Large Cap Instl | |||
| GSPQX | 20.02 | 0.12 | +0.60% |
| Goldman Sachs US Eq Div and Premium C | |||
| GSIYX | 24.29 | N/A | N/A |
| Goldman Sachs GQG Ptnrs Intl Opps R6 | |||
| CCWIX | 21.73 | -0.15 | -0.69% |
| Baird Chautauqua International Gr Instl | |||
| RYOAX | 66.89 | -1.55 | -2.26% |
| Rydex Biotechnology H | |||